Breaking News

The WHO Prepares for Monkeypox Public Health Emergency

June 15, 2022 • 9:29 am CDT
(Vax Before Travel)

The WHO/Europe held a press briefing today on the current monkeypox outbreak in the European Region. Globally, about 1,900 monkeypox virus (MPXV) potential patients have been reported.

The goal of the WHO outbreak response for monkeypox announced on June 14, 2022, is to control the outbreak and to effectively use strong public health measures to prevent the onward spread of the disease.

Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, and Dr. Andrea Ammon, Director of the European Centre for Disease Prevention & Control, announced the WHO intends to meet next week to debate confirming a Public Health Emergency.

The WHO highlighted today the current MPX outbreak risks in the context of about 750 summertime festivals and indoor and outdoor gatherings.

Most importantly, the WHO encourages MPX patients and their close-contacts to isolate themselves for up to 21 days post-diagnosis.

This WHO recommendation is relevant since the MPXV takes weeks to become visible.

However, mass MPXV vaccination is not required nor recommended 'at this time.'

Separately, the U.K. Health Security Agency detected 52 additional cases of monkeypox in England, one additional case in Scotland, and one in Wales.

This news brings the total number of confirmed MPX patients in the U.K. to 524 as of June 14, 2022.

There are currently 504 confirmed cases in England, 13 in Scotland, 2 in Northern Ireland, and 5 in Wales.

The U.S. CDC has confirmed (72) MPX patients in the USA as of June 14, 2022.

Most countries are offering select individuals the Jynneos® (MVA-BN, IMVANEX) vaccine, which was U.S. FDA approved in 2019.

Additional monkeypox outbreak news is posted at

Note: This information was manually curated for mobile readers.